Klotho Neurosciences Stock Skyrockets 621% On Preclinical Longevity Findings

(RTTNews) - Klotho Neurosciences, Inc. (KLTO) soared 621.95 percent to $1.48 on Friday, gaining $1.27, after the company announced promising preclinical study results tied to its namesake gene's role in aging. KLTO opened at $0.7184 and surged as high as $1.63 during the day on the Nasdaq. Volume exploded to over 713 million shares well above the average 11.5 million. The stock trades between $0.1140 and $7.35 over the past year.

The biogenetics firm revealed that elevating Klotho gene expression in lab models reduced age-related degeneration across multiple organs, potentially extending both healthspan and lifespan.